What is Establishment Labs' operating income?

Establishment Labs' total operating income in 2025 was -$39.01 million, based on the following breakdown: Total Gross Profit: $146.31 million Total Operating Expenses: $185.32 million

Establishment Labs (ESTA) Financials

$71.39 -3.12 (-4.19%)

Closing price 04:00 PM Eastern

Extended Trading

$72.00 +0.61 (+0.85%)

As of 05:10 PM Eastern

Compare

Annual Income Statements for Establishment Labs

This table shows Establishment Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-35	-21	-38	-38	-41	-75	-79	-85	-51
Consolidated Net Income / (Loss)	-35	-21	-38	-38	-41	-75	-79	-85	-51
Net Income / (Loss) Continuing Operations	-35	-21	-38	-38	-41	-75	-79	-85	-51
Total Pre-Tax Income	-35	-21	-38	-38	-40	-73	-79	-85	-58
Total Operating Income	-20	-24	-31	-28	-25	-40	-65	-50	-39
Total Gross Profit	18	36	55	53	85	107	107	110	146
Total Revenue	35	61	90	85	127	162	165	166	211
Operating Revenue	35	61	90	85	127	162	165	166	211
Total Cost of Revenue	17	25	35	32	41	55	58	57	65
Operating Cost of Revenue	17	25	35	32	41	55	58	57	65
Total Operating Expenses	38	60	86	80	111	146	172	160	185
Selling, General & Admin Expense	31	47	71	67	92	126	146	140	165
Research & Development Expense	6.86	13	15	14	18	20	26	20	20
Total Other Income / (Expense), net	-15	2.98	-6.85	-10	-15	-33	-14	-35	-19
Interest Expense	10	8.81	8.70	9.37	9.06	31	15	21	25
Interest & Investment Income	0.02	0.02	0.00	0.02	0.02	0.09	1.02	1.48	0.42
Other Income / (Expense), net	-4.41	12	1.85	-0.74	-5.53	-2.47	0.82	-15	5.82
Income Tax Expense	0.11	0.22	0.64	0.10	1.43	2.39	-0.08	-0.03	-6.96
Basic Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	($1.72)	($3.08)	($3.07)	($3.00)	($1.72)
Weighted Average Basic Shares Outstanding	10.23M	17.35M	20.54M	23.32M	23.97M	24.46M	25.60M	28.16M	29.62M
Diluted Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	($1.72)	($3.08)	($3.07)	($3.00)	($1.72)
Weighted Average Diluted Shares Outstanding	10.23M	17.35M	20.54M	23.32M	23.97M	24.46M	25.60M	28.16M	29.62M
Weighted Average Basic & Diluted Shares Outstanding	10.23M	17.35M	20.54M	23.32M	24.12M	24.42M	27.21M	28.85M	29.32M

This table shows Establishment Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-21	-16	-17	-17	-35	-21	-17	-11	-2.62	-13	-12
Consolidated Net Income / (Loss)	-21	-16	-17	-17	-35	-21	-17	-11	-2.62	-13	-12
Net Income / (Loss) Continuing Operations	-21	-16	-17	-17	-35	-21	-17	-11	-2.62	-13	-12
Total Pre-Tax Income	-23	-16	-17	-16	-36	-20	-16	-11	-12	-13	-12
Total Operating Income	-22	-8.83	-9.34	-13	-19	-17	-14	-4.03	-3.93	-6.51	-4.29
Total Gross Profit	21	24	29	26	30	28	35	38	46	42	48
Total Revenue	32	37	44	40	45	41	51	54	65	60	68
Operating Revenue	32	37	44	40	45	41	51	54	65	60	68
Total Cost of Revenue	11	13	15	15	14	14	16	16	19	18	20
Operating Cost of Revenue	11	13	15	15	14	14	16	16	19	18	20
Total Operating Expenses	43	33	38	39	49	45	49	42	49	49	52
Selling, General & Admin Expense	37	29	33	34	44	40	44	37	44	44	47
Research & Development Expense	5.82	4.27	5.49	4.80	5.14	5.06	5.20	4.56	5.43	5.24	5.10
Total Other Income / (Expense), net	-0.93	-6.93	-7.41	-3.03	-17	-2.85	-1.48	-6.70	-7.99	-6.58	-7.45
Interest Expense	4.34	4.38	5.19	5.31	5.95	5.85	5.96	6.20	7.24	7.09	7.03
Interest & Investment Income	0.50	0.49	0.56	0.23	0.20	0.25	0.09	0.05	0.03	0.03	0.04
Other Income / (Expense), net	2.90	-3.04	-2.78	2.05	-12	2.75	4.38	-0.54	-0.78	0.48	-0.45
Income Tax Expense	-2.51	0.44	0.43	0.51	-1.41	0.91	1.00	0.42	-9.30	0.29	0.01
Basic Earnings per Share	($0.82)	($0.58)	($0.62)	($0.59)	($1.21)	($0.70)	($0.57)	($0.38)	($0.07)	($0.45)	($0.39)
Weighted Average Basic Shares Outstanding	25.60M	27.79M	27.91M	28.25M	28.16M	29.48M	28.91M	29.62M	29.62M	29.95M	30.12M
Diluted Earnings per Share	($0.82)	($0.58)	($0.62)	($0.59)	($1.21)	($0.70)	($0.57)	($0.38)	($0.07)	($0.45)	($0.39)
Weighted Average Diluted Shares Outstanding	25.60M	27.79M	27.91M	28.25M	28.16M	29.48M	28.91M	29.62M	29.62M	29.95M	30.12M
Weighted Average Basic & Diluted Shares Outstanding	27.21M	27.51M	27.94M	28.00M	28.85M	28.92M	28.97M	29.06M	29.32M	29.43M	29.80M

This table details how cash moves in and out of Establishment Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	10	42	-15	47	-31	13	-26	50	-15
Net Cash From Operating Activities	-32	-34	-30	-13	-28	-52	-89	-59	-51
Net Cash From Continuing Operating Activities	-32	-34	-30	-13	-28	-52	-89	-59	-51
Net Income / (Loss) Continuing Operations	-35	-21	-38	-38	-41	-75	-79	-85	-51
Consolidated Net Income / (Loss)	-35	-21	-38	-38	-41	-75	-79	-85	-51
Depreciation Expense	1.94	2.81	3.29	3.35	3.72	3.87	4.17	6.83	9.56
Amortization Expense	7.05	3.32	2.43	2.05	2.48	8.59	14	7.11	4.36
Non-Cash Adjustments To Reconcile Net Income	5.83	9.27	10	9.51	14	32	8.97	29	7.67
Changes in Operating Assets and Liabilities, net	-12	-28	-7.93	11	-6.76	-22	-37	-17	-21
Net Cash From Investing Activities	-0.85	-5.73	-7.77	-5.56	-7.16	-35	-25	-16	-7.03
Net Cash From Continuing Investing Activities	-0.85	-5.73	-7.77	-5.56	-7.16	-35	-25	-16	-7.03
Purchase of Property, Plant & Equipment	-0.90	-1.73	-6.29	-2.42	-5.28	-33	-23	-8.53	-6.05
Acquisitions	-0.04	-4.00	-1.48	-3.14	-1.88	-2.02	-1.33	-7.08	-0.98
Net Cash From Financing Activities	43	82	23	65	4.05	100	86	126	40
Net Cash From Continuing Financing Activities	43	82	23	65	4.05	100	86	126	40
Repayment of Debt	-16	-5.39	-0.24	-0.28	0.00	-72	0.00	0.00	-1.02
Issuance of Debt	39	0.00	25	0.00	0.00	168	0.00	24	35
Issuance of Common Equity	28	88	0.00	64	0.00	0.00	85	99	0.00
Other Financing Activities, net	0.00	-0.70	0.54	1.09	4.05	3.87	1.69	1.94	6.95
Effect of Exchange Rate Changes	0.21	-0.14	-0.02	0.27	-0.47	-0.36	0.51	-1.46	2.71
Cash Interest Paid	2.86	5.38	5.95	6.96	6.93	5.36	5.69	9.81	21
Cash Income Taxes Paid	0.15	0.14	0.65	0.32	0.65	2.13	2.17	1.74	0.42

This table details how cash moves in and out of Establishment Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	-12	33	-18	-15	51	-21	-15	16	4.95	-7.47	3.06
Net Cash From Operating Activities	-8.15	-11	-14	-12	-21	-21	-19	-11	-0.16	-4.31	-17
Net Cash From Continuing Operating Activities	-8.15	-11	-14	-12	-21	-21	-19	-11	-0.16	-4.31	-17
Net Income / (Loss) Continuing Operations	-21	-16	-17	-17	-35	-21	-17	-11	-2.62	-13	-12
Consolidated Net Income / (Loss)	-21	-16	-17	-17	-35	-21	-17	-11	-2.62	-13	-12
Depreciation Expense	1.22	1.27	1.42	1.99	2.15	2.34	2.36	2.39	2.49	2.48	2.42
Amortization Expense	3.59	3.59	1.71	0.83	0.99	0.99	1.03	1.16	1.17	1.28	4.90
Non-Cash Adjustments To Reconcile Net Income	0.47	5.76	6.16	2.36	15	1.62	-1.79	3.97	3.87	3.99	4.31
Changes in Operating Assets and Liabilities, net	7.11	-5.57	-6.26	-0.96	-4.25	-4.96	-3.76	-7.62	-5.07	1.32	-16
Net Cash From Investing Activities	-4.62	-6.63	-4.40	-2.77	-1.82	-1.34	-2.07	-1.96	-1.66	-1.96	-3.65
Net Cash From Continuing Investing Activities	-4.62	-6.63	-4.40	-2.77	-1.82	-1.34	-2.07	-1.96	-1.66	-1.96	-3.65
Purchase of Property, Plant & Equipment	-3.66	-4.75	-1.53	-1.63	-0.62	-0.75	-1.62	-1.85	-1.82	-1.85	-3.66
Acquisitions	-0.96	-1.88	-2.87	-1.13	-1.20	-0.58	-0.45	-0.11	0.16	-0.11	0.01
Net Cash From Financing Activities	0.07	51	0.39	-0.03	74	-0.20	5.13	29	6.05	-0.86	23
Net Cash From Continuing Financing Activities	0.07	51	0.39	-0.03	74	-0.20	5.13	29	6.05	-0.86	23
Repayment of Debt	-	-	-	-	-	0.00	-	-	-	-1.17	-257
Other Financing Activities, net	0.07	1.31	0.39	-0.03	0.28	-0.20	0.13	-0.05	7.07	0.31	16
Effect of Exchange Rate Changes	0.55	-0.32	-0.21	0.35	-1.27	1.10	1.16	-0.26	0.72	-0.34	-0.16

This table presents Establishment Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	57	117	117	156	140	211	269	347	357
Total Current Assets	39	99	96	132	113	150	175	243	250
Cash & Equivalents	11	53	38	85	53	66	40	90	76
Accounts Receivable	13	18	23	19	24	35	47	65	77
Inventories, net	13	25	29	23	28	37	79	79	86
Prepaid Expenses	2.24	4.30	6.76	5.44	7.01	12	8.48	8.92	11
Plant, Property, & Equipment, net	14	13	16	16	19	51	77	78	76
Total Noncurrent Assets	4.21	4.23	4.27	7.89	7.60	10	17	26	32
Goodwill	0.47	0.47	0.47	0.47	0.47	0.47	0.47	1.21	1.21
Intangible Assets	3.40	3.45	3.44	4.15	4.37	4.61	7.99	12	9.94
Other Noncurrent Operating Assets	0.35	0.32	0.37	3.27	2.76	4.99	8.08	13	20
Total Liabilities & Shareholders' Equity	57	117	117	156	140	211	269	347	357
Total Liabilities	62	47	77	81	89	219	250	294	334
Total Current Liabilities	57	16	23	26	32	39	57	68	82
Accounts Payable	9.13	6.24	10	9.72	14	20	42	45	43
Accrued Expenses	2.33	6.13	11	15	16	17	14	17	19
Other Current Liabilities	46	4.08	2.20	1.65	1.18	1.69	1.84	6.98	20
Total Noncurrent Liabilities	4.67	31	54	56	57	180	193	225	251
Long-Term Debt	0.00	22	48	50	52	175	189	220	248
Other Noncurrent Operating Liabilities	4.67	8.32	5.53	5.70	5.00	4.83	4.36	5.88	3.96
Commitments & Contingencies	-	-	0.00	-	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-5.01	69	40	75	51	-8.19	18	53	24
Total Preferred & Common Equity	-5.01	69	40	75	51	-8.19	18	53	24
Total Common Equity	-5.01	69	40	75	51	-8.19	18	53	24
Common Stock	69	161	169	240	256	274	379	497	521
Retained Earnings	-68	-89	-127	-165	-206	-282	-360	-445	-496
Treasury Stock	-6.47	-2.85	-2.85	-2.85	-2.85	-	-2.85	-	-2.85
Accumulated Other Comprehensive Income / (Loss)	0.08	0.45	0.69	2.87	3.66	2.72	1.96	3.29	1.16

This table presents Establishment Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	209	285	271	302	285	283	333	330	339	351	352
Total Current Assets	142	209	187	204	186	183	232	229	240	246	248
Cash & Equivalents	43	90	52	73	55	40	69	55	71	68	71
Accounts Receivable	41	51	55	51	60	67	63	70	71	77	76
Inventories, net	46	56	68	72	64	67	90	95	88	87	85
Prepaid Expenses	12	11	12	7.39	7.34	8.88	8.86	9.75	9.37	14	16
Plant, Property, & Equipment, net	57	66	73	79	80	79	76	76	76	75	74
Total Noncurrent Assets	10	10	11	19	19	20	25	24	23	31	30
Goodwill	0.47	0.47	0.47	0.47	0.47	0.47	1.21	1.21	1.21	1.21	1.21
Intangible Assets	4.37	4.23	5.71	9.52	10	9.78	12	11	10	9.30	9.43
Other Noncurrent Operating Assets	5.44	5.38	5.00	8.92	8.90	10	13	12	11	20	20
Total Liabilities & Shareholders' Equity	209	285	271	302	285	283	333	330	339	351	352
Total Liabilities	225	230	240	245	240	250	295	307	323	336	330
Total Current Liabilities	41	43	50	48	42	50	69	81	72	83	65
Accounts Payable	20	24	29	31	28	34	45	56	40	42	33
Accrued Expenses	20	17	19	15	12	14	21	17	18	22	17
Other Current Liabilities	1.58	1.48	1.99	1.74	1.66	2.28	3.25	7.57	14	19	14
Total Noncurrent Liabilities	184	187	190	197	198	199	226	226	251	253	266
Long-Term Debt	179	182	185	192	194	194	220	221	246	249	262
Other Noncurrent Operating Liabilities	5.24	5.18	4.42	4.73	4.45	5.12	5.44	5.03	4.09	4.51	4.06
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-16	55	30	57	45	33	39	23	16	15	22
Total Preferred & Common Equity	-16	55	30	57	45	33	39	23	16	15	22
Total Common Equity	-16	55	30	57	45	33	39	23	16	15	22
Common Stock	278	366	371	434	438	442	504	508	511	524	543
Retained Earnings	-294	-310	-340	-376	-393	-410	-465	-482	-493	-509	-521
Treasury Stock	-	-2.85	-2.85	-2.85	-2.85	-2.85	-2.85	-2.85	-2.85	-2.85	-2.85
Accumulated Other Comprehensive Income / (Loss)	2.31	1.81	1.95	2.08	3.12	3.23	3.16	-0.37	1.43	2.37	2.16

This table displays calculated financial ratios and metrics derived from Establishment Labs' official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	-	-	29,057,868.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	29,057,868.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-1.76
Growth Metrics	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	-14	-17	-22	-20	-18	-28	-46	-35	-27
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-16.60%	-21.98%	-12.83%	-10.07%
Earnings before Interest and Taxes (EBIT)	-24	-12	-29	-29	-31	-42	-64	-65	-33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-15	-5.96	-23	-23	-24	-30	-46	-51	-19
Valuation Ratios	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-72	-33	-9.71	-27	-79	-112	-50	-40
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	-16	39	50	40	49	101	167	182	195
Increase / (Decrease) in Invested Capital	0.00	55	11	-9.83	8.96	52	66	15	13
Book Value per Share	($0.49)	$3.38	$1.92	$3.20	$2.11	($0.34)	$0.71	$1.90	$0.81
Tangible Book Value per Share	($0.87)	$3.19	$1.73	$3.00	$1.91	($0.54)	$0.39	$1.44	$0.43
Total Capital	-5.01	92	88	125	103	167	207	273	271
Total Debt	0.00	22	48	50	52	175	189	220	248
Total Long-Term Debt	0.00	22	48	50	52	175	189	220	248
Net Debt	-11	-30	10	-35	-1.51	109	149	129	172
Capital Expenditures (CapEx)	0.90	1.73	6.29	2.42	5.28	33	23	8.53	6.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-29	30	35	22	28	45	78	84	92
Debt-free Net Working Capital (DFNWC)	-18	83	73	106	81	111	118	175	168
Net Working Capital (NWC)	-18	83	73	106	81	111	118	175	168
Net Nonoperating Expense (NNE)	21	4.39	16	19	24	47	33	50	24
Net Nonoperating Obligations (NNO)	-11	-30	10	-35	-1.51	109	149	129	172
Total Depreciation and Amortization (D&A)	8.99	6.13	5.72	5.40	6.20	12	18	14	14
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	($1.72)	($3.08)	($3.07)	($3.00)	($1.72)
Adjusted Weighted Average Basic Shares Outstanding	10.23M	20.39M	23.33M	23.55M	23.97M	24.46M	25.60M	28.16M	29.62M
Adjusted Diluted Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	($1.72)	($3.08)	($3.07)	($3.00)	($1.72)
Adjusted Weighted Average Diluted Shares Outstanding	10.23M	20.39M	23.33M	23.55M	23.97M	24.46M	25.60M	28.16M	29.62M
Adjusted Basic & Diluted Earnings per Share	($3.41)	($1.22)	($1.86)	($1.63)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	10.23M	17.35M	20.54M	23.32M	24.12M	24.42M	27.21M	28.85M	29.32M
Normalized Net Operating Profit after Tax (NOPAT)	-14	-17	-22	-20	-18	-28	-46	-35	-27
Debt Service Ratios	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Establishment Labs' official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	29,057,868.00	29,320,846.00	29,430,390.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	29,057,868.00	29,320,846.00	29,430,390.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-0.09	-0.46	-0.40
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-27.97%	-20.11%	-9.15%	4.47%	41.05%	11.33%	16.28%	33.70%	-	44.71%	31.66%
EBITDA Growth	-116.41%	-123.92%	-13.57%	59.83%	-87.85%	-54.96%	29.56%	87.64%	-	79.11%	140.62%
EBIT Growth	-81.80%	-59.75%	2.00%	55.97%	-57.13%	-19.56%	19.79%	58.83%	-	57.50%	51.21%
NOPAT Growth	-68.05%	-8.26%	31.86%	37.55%	15.58%	-91.83%	-50.97%	69.37%	-	61.58%	69.59%
Net Income Growth	-51.47%	-35.67%	-2.60%	43.01%	-68.10%	-27.82%	3.42%	33.19%	-	35.38%	29.20%
EPS Growth	-46.43%	-20.83%	4.62%	47.32%	-47.56%	-20.69%	8.06%	35.59%	-	35.71%	31.58%
Operating Cash Flow Growth	41.87%	45.90%	49.88%	60.46%	-154.65%	-85.84%	-32.49%	9.72%	-	79.20%	11.47%
Free Cash Flow Firm Growth	-34.08%	10.53%	48.90%	66.70%	65.35%	59.27%	65.98%	70.30%	-	60.25%	-72.87%
Invested Capital Growth	65.57%	47.00%	25.56%	13.51%	9.11%	7.72%	2.77%	3.49%	-	2.93%	12.10%
Revenue Q/Q Growth	-18.04%	17.77%	18.70%	-8.82%	10.66%	-7.05%	23.98%	4.84%	-	-7.34%	12.80%
EBITDA Q/Q Growth	30.11%	51.31%	-28.28%	7.98%	-226.81%	59.83%	41.69%	83.85%	-	-116.60%	213.35%
EBIT Q/Q Growth	23.75%	38.21%	-2.12%	8.50%	-172.14%	52.99%	31.49%	53.03%	-	-28.20%	21.35%
NOPAT Q/Q Growth	-5.12%	60.05%	-5.77%	-40.61%	-42.10%	9.23%	16.75%	71.47%	-	-65.67%	34.11%
Net Income Q/Q Growth	29.83%	21.13%	-6.04%	2.90%	-107.00%	40.02%	19.88%	32.83%	-	-411.74%	12.21%
EPS Q/Q Growth	26.79%	29.27%	-6.90%	4.84%	-105.08%	42.15%	18.57%	33.33%	-	-542.86%	13.33%
Operating Cash Flow Q/Q Growth	74.14%	-36.87%	-26.92%	11.96%	-66.51%	0.12%	9.52%	40.01%	-	-2,560.49%	-285.20%
Free Cash Flow Firm Q/Q Growth	13.11%	23.47%	29.55%	28.92%	9.60%	10.03%	41.15%	37.96%	-	36.45%	-155.92%
Invested Capital Q/Q Growth	2.13%	5.40%	4.56%	0.85%	-1.83%	4.05%	-0.24%	1.55%	-	-0.11%	8.64%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	65.23%	65.60%	65.59%	63.93%	68.50%	67.21%	68.76%	70.09%	-	70.70%	70.64%
EBITDA Margin	-45.62%	-18.86%	-20.39%	-20.57%	-60.76%	-26.26%	-12.35%	-1.90%	-	-3.79%	3.81%
Operating Margin	-70.07%	-23.77%	-21.18%	-32.66%	-41.94%	-40.96%	-27.50%	-7.48%	-	-10.87%	-6.35%
EBIT Margin	-60.88%	-31.94%	-27.48%	-27.58%	-67.82%	-34.30%	-18.96%	-8.49%	-	-10.07%	-7.02%
Profit (Net Income) Margin	-65.09%	-43.59%	-38.94%	-41.47%	-77.57%	-50.05%	-32.35%	-20.72%	-	-22.35%	-17.39%
Tax Burden Percent	89.13%	102.78%	102.55%	103.15%	96.08%	104.62%	106.44%	103.95%	-	102.20%	100.05%
Interest Burden Percent	119.96%	132.79%	138.19%	145.79%	119.05%	139.48%	160.31%	234.77%	-	217.08%	247.51%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Return on Invested Capital (ROIC)	-60.45%	-17.52%	-13.57%	-20.04%	-27.90%	-26.68%	-18.29%	-5.29%	-	-9.08%	-5.45%
ROIC Less NNEP Spread (ROIC-NNEP)	-64.38%	-25.38%	-22.78%	-25.27%	-43.34%	-33.23%	-22.69%	-10.36%	-	-14.40%	-10.34%
Return on Net Nonoperating Assets (RNNOA)	-1,625.54%	-158.16%	-52.66%	-114.41%	-168.51%	-94.10%	-102.30%	-69.42%	-	-89.54%	-83.24%
Return on Equity (ROE)	-1,685.99%	-175.68%	-66.23%	-134.44%	-196.41%	-120.79%	-120.59%	-74.72%	-	-98.62%	-88.68%
Cash Return on Invested Capital (CROIC)	-83.35%	-69.14%	-48.62%	-34.07%	-28.74%	-29.67%	-26.30%	-23.34%	-	-13.28%	-17.95%
Operating Return on Assets (OROA)	-41.92%	-19.47%	-14.58%	-15.26%	-36.59%	-18.39%	-10.94%	-5.22%	-	-6.76%	-5.07%
Return on Assets (ROA)	-44.82%	-26.57%	-20.67%	-22.95%	-41.85%	-26.83%	-18.67%	-12.73%	-	-14.99%	-12.55%
Return on Common Equity (ROCE)	-1,685.99%	-175.68%	-66.23%	-134.44%	-196.41%	-120.79%	-120.59%	-74.72%	-	-98.62%	-88.68%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-145.42%	-184.81%	-215.86%	0.00%	-231.14%	0.00%	0.00%	-	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-15	-6.18	-6.54	-9.20	-13	-12	-9.87	-2.82	-2.75	-4.56	-3.00
NOPAT Margin	-49.05%	-16.64%	-14.83%	-22.86%	-29.36%	-28.67%	-19.25%	-5.24%	-	-7.61%	-4.45%
Net Nonoperating Expense Percent (NNEP)	3.93%	7.86%	9.22%	5.23%	15.44%	6.55%	4.40%	5.07%	-	5.32%	4.90%
Return On Investment Capital (ROIC_SIMPLE)	-7.47%	-	-	-	-4.79%	-4.58%	-4.05%	-1.07%	-1.01%	-1.73%	-1.06%
Cost of Revenue to Revenue	34.78%	34.40%	34.41%	36.07%	31.50%	32.79%	31.24%	29.91%	-	29.30%	29.36%
SG&A Expenses to Revenue	116.86%	77.87%	74.33%	84.66%	98.89%	95.94%	86.11%	69.10%	-	72.82%	69.45%
R&D to Revenue	18.44%	11.50%	12.44%	11.93%	11.56%	12.22%	10.14%	8.47%	-	8.75%	7.54%
Operating Expenses to Revenue	135.30%	89.36%	86.77%	96.59%	110.44%	108.16%	96.26%	77.57%	-	81.58%	76.99%
Earnings before Interest and Taxes (EBIT)	-19	-12	-12	-11	-30	-14	-9.72	-4.57	-4.71	-6.03	-4.74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-14	-7.01	-8.99	-8.28	-27	-11	-6.34	-1.02	-1.05	-2.27	2.57
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	36.32	24.33	27.77	36.96	24.29	30.53	54.26	72.57	-	112.62	116.88
Price to Tangible Book Value (P/TBV)	67.20	29.51	36.23	53.83	32.08	45.67	119.12	249.74	-	389.80	230.25
Price to Revenue (P/Rev)	4.05	8.89	8.26	7.90	7.77	6.91	6.96	6.22	-	7.25	10.27
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.89	8.54	7.54	7.34	7.78	7.00	7.41	7.09	-	9.45	12.80
Enterprise Value to Revenue (EV/Rev)	4.95	9.65	9.18	8.91	8.55	7.80	7.90	7.14	-	8.04	11.05
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	10.26	3.38	4.30	5.94	4.14	5.72	9.71	15.06	-	16.82	12.11
Long-Term Debt to Equity	10.26	3.38	4.30	5.94	4.14	5.72	9.71	15.06	-	16.82	12.11
Financial Leverage	25.25	6.23	2.31	4.53	3.89	2.83	4.51	6.70	-	6.22	8.05
Leverage Ratio	46.98	12.49	5.71	8.75	8.61	6.65	9.07	12.67	-	12.83	15.36
Compound Leverage Factor	56.36	16.59	7.89	12.76	10.25	9.28	14.54	29.74	-	27.86	38.02
Debt to Total Capital	91.12%	77.15%	81.14%	85.59%	80.53%	85.11%	90.67%	93.77%	-	94.39%	92.37%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Long-Term Debt to Total Capital	91.12%	77.15%	81.14%	85.59%	80.53%	85.11%	90.67%	93.77%	-	94.39%	92.37%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Common Equity to Total Capital	8.88%	22.85%	18.86%	14.41%	19.47%	14.89%	9.33%	6.23%	-	5.61%	7.63%
Debt to EBITDA	-4.10	-3.85	-3.80	-5.02	-4.28	-3.99	-4.21	-5.44	-	-23.29	-148.02
Net Debt to EBITDA	-3.23	-2.39	-2.73	-4.00	-2.52	-2.74	-3.17	-3.88	-	-16.91	-107.77
Long-Term Debt to EBITDA	-4.10	-3.85	-3.80	-5.02	-4.28	-3.99	-4.21	-5.44	-	-23.29	-148.02
Debt to NOPAT	-4.15	-4.18	-4.51	-5.20	-6.28	-5.42	-5.03	-6.55	-	-12.43	-19.93
Net Debt to NOPAT	-3.27	-2.59	-3.24	-4.14	-3.69	-3.72	-3.78	-4.67	-	-9.02	-14.51
Long-Term Debt to NOPAT	-4.15	-4.18	-4.51	-5.20	-6.28	-5.42	-5.03	-6.55	-	-12.43	-19.93
Altman Z-Score	0.63	2.65	2.19	1.85	1.64	1.40	1.35	1.28	-	2.09	3.79
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.06	4.24	4.44	3.62	3.56	3.36	2.84	3.33	-	2.96	3.84
Quick Ratio	1.52	2.58	2.74	2.12	2.28	1.92	1.54	1.97	-	1.75	2.27
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-82	-62	-44	-31	-28	-25	-15	-9.29	-16	-10	-26
Operating Cash Flow to CapEx	-222.50%	-234.93%	-925.70%	-763.07%	-3,352.02%	-2,752.32%	-1,154.74%	-608.77%	-	-232.60%	-453.85%
Free Cash Flow to Firm to Interest Expense	-18.82	-14.27	-8.49	-5.89	-4.76	-4.35	-2.52	-1.50	-	-1.43	-3.68
Operating Cash Flow to Interest Expense	-1.88	-2.55	-2.73	-2.35	-3.49	-3.54	-3.15	-1.81	-	-0.61	-2.36
Operating Cash Flow Less CapEx to Interest Expense	-2.72	-3.63	-3.02	-2.65	-3.59	-3.67	-3.42	-2.11	-	-0.87	-2.88
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.61	0.53	0.55	0.54	0.54	0.58	0.61	-	0.67	0.72
Accounts Receivable Turnover	4.01	3.39	2.72	2.51	2.97	2.98	2.73	2.75	-	3.27	3.37
Inventory Turnover	1.00	0.92	0.85	0.79	0.71	0.70	0.73	0.77	-	0.78	0.81
Fixed Asset Turnover	2.57	2.29	2.08	2.01	2.14	2.19	2.28	2.45	-	3.04	3.27
Accounts Payable Turnover	1.89	2.12	1.95	1.69	1.31	1.50	1.38	1.61	-	1.58	1.64
Days Sales Outstanding (DSO)	90.99	107.64	134.30	145.39	123.03	122.29	133.80	132.54	-	111.54	108.20
Days Inventory Outstanding (DIO)	364.08	397.13	428.17	461.11	511.12	519.04	498.86	474.64	-	470.14	451.99
Days Payable Outstanding (DPO)	193.43	171.81	187.41	216.21	279.03	242.96	264.43	226.55	-	230.98	223.01
Cash Conversion Cycle (CCC)	261.64	332.95	375.06	390.30	355.12	398.38	368.23	380.63	-	350.70	337.18
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	167	176	184	186	182	190	189	192	195	195	212
Invested Capital Turnover	1.23	1.05	0.92	0.88	0.95	0.93	0.95	1.01	-	1.19	1.22
Increase / (Decrease) in Invested Capital	66	56	37	22	15	14	5.11	6.48	13	5.56	23
Enterprise Value (EV)	817	1,504	1,389	1,364	1,419	1,328	1,402	1,363	-	1,845	2,716
Market Capitalization	668	1,385	1,250	1,209	1,290	1,177	1,235	1,188	-	1,665	2,525
Book Value per Share	$0.71	$2.09	$1.64	$1.17	$1.90	$1.34	$0.79	$0.56	$0.81	$0.50	$0.73
Tangible Book Value per Share	$0.39	$1.73	$1.25	$0.80	$1.44	$0.89	$0.36	$0.16	$0.43	$0.15	$0.37
Total Capital	207	249	239	227	273	259	244	263	271	263	283
Total Debt	189	192	194	194	220	220	221	246	248	249	262
Total Long-Term Debt	189	192	194	194	220	220	221	246	248	249	262
Net Debt	149	119	139	155	129	151	166	176	172	180	191
Capital Expenditures (CapEx)	3.66	4.75	1.53	1.63	0.62	0.75	1.62	1.85	1.82	1.85	3.66
Debt-free, Cash-free Net Working Capital (DFCFNWC)	78	83	90	93	84	93	94	97	92	95	112
Debt-free Net Working Capital (DFNWC)	118	156	144	132	175	163	148	168	168	163	183
Net Working Capital (NWC)	118	156	144	132	175	163	148	168	168	163	183
Net Nonoperating Expense (NNE)	5.06	10	11	7.48	21	8.85	6.72	8.33	-0.14	8.82	8.75
Net Nonoperating Obligations (NNO)	149	119	139	153	129	151	166	176	172	180	191
Total Depreciation and Amortization (D&A)	4.82	4.86	3.13	2.82	3.14	3.33	3.39	3.54	3.66	3.76	7.32
Debt-free, Cash-free Net Working Capital to Revenue	47.06%	53.08%	59.23%	60.60%	50.84%	54.91%	52.86%	50.79%	-	41.19%	45.57%
Debt-free Net Working Capital to Revenue	71.30%	99.93%	95.30%	86.53%	105.26%	95.55%	83.66%	87.77%	-	70.86%	74.52%
Net Working Capital to Revenue	71.30%	99.93%	95.30%	86.53%	105.26%	95.55%	83.66%	87.77%	-	70.86%	74.52%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.82)	($0.58)	($0.62)	($0.59)	($1.21)	($0.70)	($0.57)	($0.38)	($0.07)	($0.45)	($0.39)
Adjusted Weighted Average Basic Shares Outstanding	25.60M	27.79M	27.91M	28.25M	28.16M	29.48M	28.91M	29.62M	29.62M	29.95M	30.12M
Adjusted Diluted Earnings per Share	($0.82)	($0.58)	($0.62)	($0.59)	($1.21)	($0.70)	($0.57)	($0.38)	($0.07)	($0.45)	($0.39)
Adjusted Weighted Average Diluted Shares Outstanding	25.60M	27.79M	27.91M	28.25M	28.16M	29.48M	28.91M	29.62M	29.62M	29.95M	30.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.21M	27.51M	27.94M	28.00M	28.85M	28.92M	28.97M	29.06M	29.32M	29.43M	29.80M
Normalized Net Operating Profit after Tax (NOPAT)	-15	-6.18	-6.54	-9.20	-13	-12	-9.87	-2.82	-2.75	-4.56	-3.00
Normalized NOPAT Margin	-49.05%	-16.64%	-14.83%	-22.86%	-29.36%	-28.67%	-19.25%	-5.24%	-	-7.61%	-4.45%
Pre Tax Income Margin	-73.03%	-42.41%	-37.97%	-40.20%	-80.74%	-47.84%	-30.39%	-19.94%	-	-21.87%	-17.38%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-4.43	-2.71	-2.34	-2.09	-5.07	-2.42	-1.63	-0.74	-	-0.85	-0.67
NOPAT to Interest Expense	-3.57	-1.41	-1.26	-1.73	-2.20	-2.03	-1.66	-0.45	-	-0.64	-0.43
EBIT Less CapEx to Interest Expense	-5.27	-3.79	-2.63	-2.40	-5.18	-2.55	-1.91	-1.03	-	-1.11	-1.19
NOPAT Less CapEx to Interest Expense	-4.41	-2.50	-1.56	-2.04	-2.30	-2.16	-1.93	-0.75	-	-0.90	-0.95
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Establishment Labs (NASDAQ:ESTA) showed strong top-line momentum in Q2 2026, but the company remains unprofitable and highly leveraged. Revenue reached $67.5 million, up 31.7% from $51.3 million in Q2 2025 and approximately 64% from $41.2 million in Q2 2022. Gross profit rose to $47.7 million, with gross margin improving to approximately 70.6%, compared with 62.9% a year earlier.

Operating performance also improved. The operating loss narrowed to $4.3 million in Q2 2026 from $14.1 million in Q2 2025, helped by higher revenue and better gross margins. However, interest expense of $7.0 million and other expenses pushed the company to a net loss of $11.7 million, or $0.39 per share. Although this was an improvement from the $13.4 million loss in Q1 2026 and the $16.7 million loss in Q2 2025, ESTA has continued to report quarterly losses throughout the periods provided.

Revenue growth is accelerating: Q2 2026 revenue of $67.5 million was the highest among the comparable quarterly periods provided, increasing from $31.6 million in Q4 2023 and $37.2 million in Q1 2024.
Gross margins improved materially: The Q2 2026 gross margin was approximately 70.6%, up from 68.1% in Q1 2026 and 62.9% in Q2 2025, indicating improved profitability at the product level.
Operating losses are narrowing: The Q2 2026 operating loss of $4.3 million was substantially better than the $14.1 million loss in Q2 2025 and the $16.9 million loss in Q1 2025.
Net losses have improved from prior-year levels: The Q2 2026 net loss of $11.7 million compared favorably with losses of $13.4 million in Q1 2026, $13.4 million in Q2 2025 and $37.1 million in Q2 2022.
Cash increased in the latest quarter: Cash and equivalents rose to $71.2 million at June 30, 2026, from $68.1 million at March 31, 2026 and $54.6 million at June 30, 2025.
Current assets provide near-term flexibility: Current assets of $247.7 million exceeded current liabilities of $64.6 million, producing a current ratio of approximately 3.8 times.
Operating cash flow remains negative but improved year over year: Cash used in operations was $16.6 million in Q2 2026, compared with $18.8 million in Q2 2025. This was still a significant cash outflow despite the improvement in net losses.
Working capital remains a major cash-use factor: Changes in operating assets and liabilities consumed $16.5 million in Q2 2026. Accounts receivable and inventory totaled approximately $160.6 million, tying up a substantial amount of capital relative to quarterly revenue.
Leverage is very high: Long-term debt stood at $261.7 million and total liabilities reached $330.3 million at June 30, 2026. Liabilities represented approximately 94% of total assets, while shareholders’ equity was only $21.6 million.
Interest expense continues to weigh on results: Q2 2026 interest expense was $7.0 million, exceeding the operating loss and limiting the benefit of improving gross profitability.

ESTA’s balance sheet has expanded considerably since Q2 2022, when total assets were $199.9 million, but much of that expansion has been funded with debt and equity financing rather than internally generated cash. Long-term debt increased from $145.5 million in Q2 2022 to $261.7 million in Q2 2026. At the same time, retained earnings remained deeply negative at $520.9 million, reflecting the company’s cumulative losses.

The latest cash increase also requires careful interpretation. ESTA generated $3.1 million of net cash during Q2 2026 despite using $16.6 million in operating cash and $3.6 million for capital expenditures. Financing cash flow was positive $23.5 million, offsetting the operating and investing outflows. The cash flow statement reports a $257.2 million debt repayment alongside positive financing cash flow and a higher period-end debt balance, suggesting refinancing, reclassification or other debt activity that investors should review in the company’s filings.

Overall, the statements show a company with attractive revenue growth, improving gross margins and a narrowing operating deficit. However, ESTA has not yet achieved positive operating cash flow or net income, and its high debt burden creates substantial interest and refinancing risk. Investors should focus on whether revenue growth can eventually produce sustained positive operating cash flow before the company needs additional financing.

09/10/26 05:21 PM ETAI Generated. May Contain Errors.

Establishment Labs Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Establishment Labs' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Establishment Labs' net income appears to be on an upward trend, with a most recent value of -$51.06 million in 2025, rising from -$34.90 million in 2017. The previous period was -$84.60 million in 2024. View Establishment Labs' forecast to see where analysts expect Establishment Labs to go next.

Establishment Labs' total operating income in 2025 was -$39.01 million, based on the following breakdown:

Total Gross Profit: $146.31 million
Total Operating Expenses: $185.32 million

Over the last 8 years, Establishment Labs' total revenue changed from $34.68 million in 2017 to $211.08 million in 2025, a change of 508.6%.

Establishment Labs' total liabilities were at $333.62 million at the end of 2025, a 13.6% increase from 2024, and a 437.2% increase since 2017.

In the past 8 years, Establishment Labs' cash and equivalents has ranged from $10.86 million in 2017 to $90.35 million in 2024, and is currently $75.57 million as of their latest financial filing in 2025.

Over the last 8 years, Establishment Labs' book value per share changed from -0.49 in 2017 to 0.81 in 2025, a change of -265.4%.

Related Companies

Financial statements for NASDAQ:ESTA last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Establishment Labs (ESTA) Financials

Financials Breakdown Chart

Key Financial Trends

Establishment Labs Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Establishment Labs (ESTA) Financials

Annual Income Statements for Establishment Labs

Quarterly Income Statements for Establishment Labs

Annual Cash Flow Statements for Establishment Labs

Quarterly Cash Flow Statements for Establishment Labs

Annual Balance Sheets for Establishment Labs

Quarterly Balance Sheets for Establishment Labs

Annual Metrics And Ratios for Establishment Labs

Quarterly Metrics And Ratios for Establishment Labs

Financials Breakdown Chart

Key Financial Trends

Establishment Labs Financials - Frequently Asked Questions

When does Establishment Labs' fiscal year end?

How has Establishment Labs' net income changed over the last 8 years?

What is Establishment Labs' operating income?

How has Establishment Labs' revenue changed over the last 8 years?

How much debt does Establishment Labs have?

How much cash does Establishment Labs have?

How has Establishment Labs' book value per share changed over the last 8 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools